1O' Riardan S. Chronic kidney disease and older people-implications of the publication of the Part 2 of the National Service Framework for Renal Services.Age Ageing, 2005, 34:546-548.
2Zoccali C. Cardiorenal risk as a new frontier of nephrology:research needs and areas for intervention. Nephrol Dial Transplant, 2002,17[Suppl 11 ]:50-54.
3Ritz E. Heart and kidney: fatal twins? Am J Med, 2006,119(5A):31S-39S.
4Eckardt KU. Cardiovascular consequences of renal anemia and erythropoietin therapy. Nephrol Dial Transplant, 1999,14:1317-1323.
5Robinson RF, Nahata MC, Sparks E, et al. Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatr Nephrol , 2005, 20:64-68.
6Mende CW. Improving antihypertensive therapy in patients with diabetic nephropathy. South Med J, 2006, 99(2): 150-157.
7Marin R. Fernandez-Vega F, Gorostidi M, et al. Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study. J Hypertens, 2006, 24(2):395-402.
8Lameire N, Van Biesen W. Hypervolemia in peritoneal dialysis patients. J Nephrol, 2004, 17(Suppl 8): s58-66.
9London G. Left ventricular hypertrophy: why does it happen?Nephrol Dial Transplant, 2003, 18 [Suppl 8]: viii2-viii6.
10Block GA, Hulhert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis, 1998, 31:607-617.
8O'Riordan S. Chronic kidney disease and older people -implications of the publication of the part 2 of the National Service Framework for Renal Services [ J ]. Age Ageing, 2005 ;34(6) :546 -548
9Pitt B. Revascularization in patients with chronic kidney disease:the state of the ARTS[J]. Eur Heart J,2005;2,fi (15) : 1456 - 1457
10Smilde TD, Hillege HL, Naris G, et al.Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival[J] .Am Heart J,2004;148(1) :165 -172
